And I think were starting to see hence that, as theyve seen on the adult side, that the roll out of these medications could reinforce some of the inequities we see in access to care and treatment. GLP-1 prescribing for kids and teens remains limited, study shows Historically, GLP-1 medication use in the pediatric population was limited almost exclusively to a small percentage of kids with Type 2 diabetes
The mean follow-up time was 3.06 years and 3.28 for GLP-1 RA nonusers and users, respectively
Zander, M., Madsbad, S., Madsen, J
ChouchaniETPellVRGaudeEAksentijevicDSundierSYRobbELet alIschaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS
Because recent evidence shows little benefit on cardiovascular outcomes from adding extended-release niacin to statin therapy, or from raising HDL-cholesterol levels, niacin is no longer considered standard of care for reducing cardiovascular risk